Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
11.43
-0.38 (-3.22%)
At close: Jun 27, 2025, 4:00 PM
11.43
0.00 (0.00%)
After-hours: Jun 27, 2025, 4:34 PM EDT
Rapport Therapeutics Market Cap
Rapport Therapeutics has a market cap or net worth of $417.17 million as of June 27, 2025. Its market cap has decreased by -43.44% in one year.
Market Cap
417.17M
Enterprise Value
139.63M
1-Year Change
-43.44%
Ranking
Category
Stock Price
11.43
Market Cap Chart
Since the IPO on June 7, 2024, Rapport Therapeutics's market cap has decreased from $601.40M to $417.17M, a decrease of -30.63%. That is a compound annual growth rate of -29.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 417.17M | -35.71% |
| Dec 31, 2024 | 648.87M | 7.89% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.28B |
| Johnson & Johnson | 366.40B |
| AbbVie | 327.47B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 239.05B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |